571 related articles for article (PubMed ID: 16405439)
21. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
Robak T
Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
[TBL] [Abstract][Full Text] [Related]
22. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.
Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H
Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868
[TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.
Mozziconacci MJ; Rosenauer A; Restouin A; Fanelli M; Shao W; Fernandez F; Toiron Y; Viscardi J; Gambacorti-Passerini C; Miller WH; Lafage-Pochitaloff M
Genes Chromosomes Cancer; 2002 Nov; 35(3):261-70. PubMed ID: 12353268
[TBL] [Abstract][Full Text] [Related]
24. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
[TBL] [Abstract][Full Text] [Related]
25. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia.
Abe S; Ishikawa I; Harigae H; Sugawara T
Cancer Genet Cytogenet; 2008 Jul; 184(1):44-7. PubMed ID: 18558288
[TBL] [Abstract][Full Text] [Related]
26. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
Wang Z; Sun G; Shen Z; Chen S; Chen Z
Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
[TBL] [Abstract][Full Text] [Related]
27. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.
Duprez E; Wagner K; Koch H; Tenen DG
EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of acute promyelocytic leukemia with trans-retinoic acid. Experience of the Santa Maria Hospital, Medical School of Lisbon].
De Lacerda JF; Do Carmo JA; De Moura MC; Guerra ML; Lopes C; Raposo J; Melo A; De Oliveira JJ; De Lacerda JM
Acta Med Port; 1994 Dec; 7(12):717-24. PubMed ID: 7717119
[TBL] [Abstract][Full Text] [Related]
29. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
30. [Expression level changes of inhibitor of differentiation 1 during ATRA-induced acute promyelocytic leukemia cells differentiation].
Zheng PZ; Zhao CJ; Fan HY; Chen YL
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):366-9. PubMed ID: 19031736
[TBL] [Abstract][Full Text] [Related]
31. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
[TBL] [Abstract][Full Text] [Related]
32. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
Randolph TR
Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
[TBL] [Abstract][Full Text] [Related]
33. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
He LZ; Merghoub T; Pandolfi PP
Oncogene; 1999 Sep; 18(38):5278-92. PubMed ID: 10498880
[TBL] [Abstract][Full Text] [Related]
34. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
35. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
[TBL] [Abstract][Full Text] [Related]
36. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
García-Casado Z; Cervera J; Valencia A; Pajuelo JC; Mena-Duran AV; Barragán E; Bolufer P; Sanz MA
Cancer Genet Cytogenet; 2006 Jul; 168(1):73-6. PubMed ID: 16772124
[TBL] [Abstract][Full Text] [Related]
37. [A study on the relationship between morphology and gene heterogeneity in acute promyelocytic leukemia].
Xiong S; Chen Z; Huang W
Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):165-8. PubMed ID: 7648936
[TBL] [Abstract][Full Text] [Related]
38. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
Jing Y; Hellinger N; Xia L; Monks A; Sausville EA; Zelent A; Waxman S
Cancer Res; 2005 Sep; 65(17):7847-55. PubMed ID: 16140954
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid as a single agent induces complete remission in a patient with acute leukemia of M2a subtype.
Chen Z; Wang Y; Wang W; Gong J; Xue Y
Chin Med J (Engl); 2002 Jan; 115(1):58-61. PubMed ID: 11930660
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all-trans-retinoic acid].
Tsurugano S; Togawa A; Soda Y; Miwa A; Takaku F; Yuo A; Yamada K; Hirai H
Rinsho Ketsueki; 1994 Jan; 35(1):36-41. PubMed ID: 8139100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]